{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP03758",
    "Peptide Name": "mBMAP-28 (synthetic AMPs, XXA, UCLL1c; BBMm)",
    "Source": "segment substitution",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "GGLRSLGRKILRAWKKYGPQATPATRQ",
    "Sequence Length": 27,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Antifungal",
      "candidacidal"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 8,
    "Boman Index": 2.4,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "30%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Peptide design: the C-terminal hydrophobic tail (residues 20 and beyond) has been repalced with a less hydrophobic tail.Sequence analysis: APD analysis reveals this sequence is most similar (75%) toBMAP-28GRAVY: -0.91; M Wt: 3010.535; M formula: C134H226N45O34; Mol ex coeff: 7040.Activity: Active against E. coli ATCC 25922 ML-35 (MIC 0.5-1 uM), S. typhimurium ATCC 14028 (MIC 1 uM), P. aeruginosa ATCC 27853 (MIC 0.5 uM), S. marcescens ATCC 8100 (MIC 4 uM), S. aureus ATCC 25923  (MIC 8 uM) but MRSA >64 uM, S. epidermidis ATCC 12228 (MIC 2 uM), B. megaterium Bm11 (MIC 2 uM), C. albicans (MIC 8 uM), and C. neoformans (MIC 4 uM).Toxicity: low hemo.lytic to hRBC at 100 uM (3.3%), HC50 >100 uM.Structure: The peptide became more helical with the titration of TFE.MOA:bacteria: it permeabilizes the inner membrane of E. coli ML-35.",
    "Author": "Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M. 1996",
    "Reference": "J Biol Chem. 1996 Nov 8;271(45):28375-81. doi: 10.1074/jbc.271.45.28375.8910461.",
    "Title": "Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities"
  },
  "3D Structure": []
}